For overwhelmed cancer patients, the individualized assistance offered by patient navigation programs can be a game-changer.June 9, 2023Check out STAT+Sponsored By Marie Miller for STAT STAT+ | The woman behind AstraZeneca's cancer winning streak This year, again, the biggest data at the ASCO meeting came from AstraZeneca. Here's how it went from a laggard in cancer to a dominant force. By Matthew Herper STAT+ | ASCO showcased the payoff for new cancer medicines: longer lives The biggest example came with results of Tagrisso in non-small cell lung cancer. There was new support, too, for CAR-T therapy. By Matthew Herper and Angus Chen and Adam Feuerstein and Katherine MacPhail STAT+ | Buoyed by cancer advances, new ASCO president also stresses honest prognosis ASCO's Lynn Schuchter aims to help oncologists spend more time on patients and to integrate palliative care for times when treatment fails. By Katherine MacPhail National Cancer Institute/NIH Opinion: Want to help with medical breakthroughs? Donate some extra cells to a biobank I donated my neuroendocrine tumors to a biobank. Biobanks are also utilized in research on diabetes, Alzheimer's, Lyme disease, and more. By Kimberly M. Baker STAT+ | FDA will allow troubled chemotherapy maker to resume distribution of cancer drugs in short supply The FDA will allow troubled a chemotherapy maker to resume distribution of drugs in short supply, with strict requirements. By Ed Silverman More around STATCheck out more exclusive coverage with a STAT+ subscriptionRead premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.Enjoying Cancer Briefing? Tell us about your experienceContinue reading the latest health & science news with the STAT appDownload on the App Store or get it on Google Play STAT, 1 Exchange Place, Boston, MA©2023, All Rights Reserved.I no longer wish to receive STAT emailsUpdate Newsletter Preferences • Contact Us • Advertise with Us • View in Browser
No comments